Researchers reporting in The Lancet on the LiGHT Study concluded that a change in the clinical practice pattern of how we treat glaucoma should be implemented so that glaucoma laser treatment was a first choice treatment, rather than eye drops which is the typical approach to glaucoma treatment. The LiGHT Study compared eye drops to glaucoma Selective Laser Trabeculoplasty (SLT) treatment in terms of lowering intraocular pressure, health related quality of life, cost and cost effectiveness. The data was gathered and analyzed and concluded that Selective Laser Trabeculoplasty (SLT) should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice.
If you or someone you know is at risk for glaucoma, has ocular hypertension or is being treated for glaucoma, please be certain you have regular eye exams with glaucoma testing to prevent vision loss. Ask your eye doctor about treatment options such as SLT for glaucoma when you schedule your exam at Center for Sight 508-730-2020, visit Center for Sight or
www.facebook.com/centerforsightfallriver.
Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.
